Atlantic Coastal Acquisition II Stock Price, News & Analysis
Company Description
Atlantic Coastal Acquisition II (NASDAQ: ACAB) is a publicly traded company in the Biological Products, (no Disgnostic Substances) sector. The company has a market capitalization of $84.4M, ranking #5,195 among all listed U.S. companies by market cap.
ACAB stock has declined 45.5% over the past year. Shares last traded at $11.00.
This page provides a comprehensive overview of ACAB stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Atlantic Coastal Acquisition II (ACAB) stock last traded at $11.00. Over the past 12 months, the stock has lost 45.5%. At a market capitalization of $84.4M, ACAB is classified as a micro-cap stock with approximately 8.0M shares outstanding.
Latest News
Atlantic Coastal Acquisition II has 7 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include acquisition. View all ACAB news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ACAB Company Profile & Sector Positioning
Atlantic Coastal Acquisition II (ACAB) operates in the Biological Products, (no Disgnostic Substances) sector and is listed on the NASDAQ.